UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031505
Receipt number R000035949
Scientific Title Randomized-controlled trial to evaluate the efficacy of Lusutrombopag on EVL-AS therapy in thrombocytopenic patients
Date of disclosure of the study information 2018/02/27
Last modified on 2020/09/30 19:22:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized-controlled trial to evaluate the efficacy of Lusutrombopag on EVL-AS therapy in thrombocytopenic patients

Acronym

Randomized-controlled trial to evaluate the efficacy of Lusutrombopag on EVL-AS therapy in thrombocytopenic patients

Scientific Title

Randomized-controlled trial to evaluate the efficacy of Lusutrombopag on EVL-AS therapy in thrombocytopenic patients

Scientific Title:Acronym

Randomized-controlled trial to evaluate the efficacy of Lusutrombopag on EVL-AS therapy in thrombocytopenic patients

Region

Japan


Condition

Condition

Liver Cirrhosis,Esophageal varices

Classification by specialty

Medicine in general Gastroenterology Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of Lusutrombopag on EVL-AS therapy in thrombocytopenic patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

total procedure time of EIS

Key secondary outcomes

number of balloon compression times, bleeding time, delayed post EIS bleeding, adverse events


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Lusutrombopag 3mg/day, oral intake for 7 days

Interventions/Control_2

no medication

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

eligible patients had liver cirrhosis (Child-Pugh score A or B), and a platelet count of more than 40000 to less than 80000 per cubic millimeter.

Key exclusion criteria

Patients were excluded if they had a history of hypersensitivity of lusutrombopag, or if
they were pregnant, or they had a history of arterial or venous thrombosis with on-going risk factors for thrombosis, or had a severe liver damages (Child-Pugh score C), or had a severe renal dysfunction, or took anticoagulant or antiplatelet drug.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Naoki
Middle name
Last name Hosoe

Organization

Keio University school of medicine

Division name

Center for Diagnostic and Therapeutic Endoscopy

Zip code

160-8582

Address

35 shinanomachi shinjuku-ku tokyo Japan

TEL

03-5363-3238

Email

nhosoe@z5.keio.jp


Public contact

Name of contact person

1st name Kaoru
Middle name
Last name Takabayashi

Organization

Keio University school of medicine

Division name

Center for Diagnostic and Therapeutic Endoscopy

Zip code

160-8582

Address

35 shinanomachi shinjuku-ku tokyo Japan

TEL

03-5363-3238

Homepage URL


Email

kaoru0902@yahoo.co.jp


Sponsor or person

Institute

Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University,

Institute

Department

Personal name



Funding Source

Organization

Center for Diagnostic and Therapeutic Endoscopy, division of Keio University school of medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

National Hospital Organization Tokyo Medical Center
SANOKOUSEI GENERAL HOSPITAL
Kitasato Institute Hospital
Tokyo Dental College Ichikawa General Hospital
Tokyo Saiseikai Central Hospital
Yokohama Municipal Citizen's Hospital
Eiju Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University school of medicine

Address

35 shinanomachi shinjuku-ku tokyo Japan

Tel

03-5363-3879

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

慶應義塾大学病院(東京都)
独立行政法人国立病院機構東京医療センター(東京都)
佐野厚生総合病院(栃木県) 
北里大学北里研究所病院(東京都) 
東京歯科大学市川総合病院(千葉県) 
東京都済生会中央病院(東京都) 
横浜市立市民病院(神奈川県) 
永寿総合病院(東京都)


Other administrative information

Date of disclosure of the study information

2018 Year 02 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 02 Month 22 Day

Date of IRB

2018 Year 03 Month 01 Day

Anticipated trial start date

2018 Year 03 Month 05 Day

Last follow-up date

2022 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 02 Month 27 Day

Last modified on

2020 Year 09 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035949


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name